Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden

Family Practice

Volumn 23, Issue 1, 2006, Pages 60-64

  Midlöv, Patrik ^a,b   Bondesson, Åsa ^b   Eriksson, Tommy ^b   Nerbrand, Christina ^b   Höglund, Peter ^b  

^a Tabelund Primary Health Care Centre   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ageing; Family medicine; Postgraduate education; Prescribing

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; FLUNITRAZEPAM; LONG ACTING DRUG; NEUROLEPTIC AGENT; NITRAZEPAM; BENZODIAZEPINE;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DELIRIUM; EXTRAPYRAMIDAL SYMPTOM; GENERAL PRACTICE; GERIATRICS; HUMAN; MEDICAL EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; RANDOMIZATION; SWEDEN; CONTINUING EDUCATION; GENERAL PRACTITIONER; GERIATRIC PATIENT; PRIMARY HEALTH CARE;

AGED; AGED, 80 AND OVER; AGING; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; BENZODIAZEPINES; CLINICAL COMPETENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; FEMALE; HUMANS; MALE; PROGRAM EVALUATION; RISK FACTORS; SWEDEN;

EID: 31744446465     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/cmi105     Document Type: Article

References (25)

1. Swedish drug - prescription survey 2002 (Swedish). Stockholm; 2002.
2. Ekedahl A, Andersson SI, Hovelius B, Molstad S, Liedholm H, Melander A. Drug prescription attitudes and behaviour of general practitioners. Effects of a problem-oriented educational programme. Eur J Clin Pharmacol 1995; 47: 381-387.
3. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; 2.
4. Davis DA, Thomson MA, Oxman AD and Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-705.
5. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50: 172-175.
6. Reeve JF, Peterson GM, Rumble RH, Jaffrey R. Programme to improve the use of drugs in older people and involve general practitioners in community education. J Clin Pharm Ther 1999; 24: 289-297.
7. Wahlstrom R, Diwan VK, Tomson G, Oke' T, Beermann B. An educational experiment in primary care in Sweden. Eur J Gen Pract 1997; 3: 96-102.
8. Witt K, Knudsen E, Ditlevsen S, Hollnagel H. Academic detailing has no effect on prescribing of asthma medication in Danish general practice: A 3-year randomized controlled trial with 12-monthly follow-ups. Fam Pract 2004; 21: 248-253.
9. Borgiel AE, Williams JI, Davis DA et al. Evaluating the effectiveness of 2 educational interventions in family practice. CMAJ 1999; 161: 965-970.
10. Jackson C, McGuire T, Dommers E, Nyst P. A GP prescribing educational intervention involving a medication panel. Aust Fam Physician 1999; 28: 1191-1195.
11. Flaherty JH. Psychotherapeutic agents in older adults. Commonly prescribed and over- the-counter remedies: Causes of confusion. Clin Geriatr Med 1998; 14: 101-127.
12. Apoteket. Swedish Drug Statistics; 2002.
13. Lechin F, van der Dijs B, Benaim M. Benzodiazepines: Tolerability in elderly patients. Psychother Psychosom 1996; 65: 171-182.
14. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: Incidence, prevention and management. Drug Saf 1999; 21: 101-122.
15. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987; 107: 169-173.
16. Karlsson I. Drugs that induce delirium. Dement Geriatr Cogn Disord 1999; 10: 412-425.
17. Foy A, O'Connell D, Henry D, Kelly J, Cocking S, Halliday J. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol A Biol Sci Med Sci 1995; 50: M99-106.
18. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: Effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158: 892-898.
19. Panneman MJ, Goettsch WG, Kramarz P, Herings RM. The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: A Pharmo study. Drugs Aging 2003; 20: 833-839.
20. Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int Clin Psychopharmacol 1995; 9(Suppl 5): 21-27.
21. Rosen J, Bohon S, Gershon S. Antipsychotics in the elderly. Acta Psychiatr Scand 1990; 358(Suppl): 170-175.
22. Popli AP, Hegarty JD, Siegel AJ, Kando JC, Tohen M. Transfer of psychiatric inpatients to a general hospital due to adverse drug reactions. Psychosomatics 1997; 38: 35-37.
23. Avorn J, Soumerai SB, Everitt DE et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992; 327: 168-173.
24. Ray WA, Blazer DGd, Schaffner W, Federspiel CF, Fink R. Reducing long-term diazepam prescribing in office practice. A controlled trial of educational visits. JAMA 1986; 256: 2536-2539.
25. Zwar NA, Wolk J, Gordon JJ, Sanson-Fisher RW. Benzodiazepine prescribing by GP registrars. A trial of educational outreach. Aust Fam Physician 2000; 29: 1104-1107.